WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Qiongzhou Strait faced peak of return travel during Spring Festival migrationThingyan water festival kicks off in MyanmarCommentary: China's proGirl, five, dies in horror crash with a lorry while riding her bike outside the school gatesCPC education campaign draws wide attentionXi Meets Merieux Foundation President and His WifeCommentary: China's proNews Analysis: Türkiye's economic woes far from over amid tumbling currency, looming debtMeeting of the CIS Council of Foreign Ministers held in MinskIgnoring reality